134 related articles for article (PubMed ID: 27740515)
21. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
[TBL] [Abstract][Full Text] [Related]
22. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
23. IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.
Zekri AR; Salama H; Medhat E; Bahnassy AA; Morsy HM; Lotfy MM; Ahmed R; Darwish T; Marei MS
Asian Pac J Cancer Prev; 2014; 15(17):7213-8. PubMed ID: 25227816
[TBL] [Abstract][Full Text] [Related]
24. Genetic variations of the NPC1L1 gene associated with hepatitis C virus (HCV) infection and biochemical characteristics of HCV patients in China.
Zhang AM; Zhang CL; Song Y; Zhao P; Feng Y; Wang B; Li Z; Liu L; Xia X
Int J Infect Dis; 2016 Dec; 53():6-11. PubMed ID: 27769799
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor rs3782905 and vitamin D binding protein rs7041 polymorphisms are associated with hepatocellular carcinoma susceptibility in cirrhotic HCV patients.
El-Masry AS; Medhat AM; El-Bendary M; Mohamed RH
BMC Med Genomics; 2023 Dec; 16(1):319. PubMed ID: 38066559
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
[TBL] [Abstract][Full Text] [Related]
29.
Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
[TBL] [Abstract][Full Text] [Related]
30. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
[TBL] [Abstract][Full Text] [Related]
31. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
32. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
33. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
34. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
[TBL] [Abstract][Full Text] [Related]
35. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
36. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
37. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
38. IL17A gene polymorphisms: relationship to predisposition for chronic viral hepatitis and progression to liver cirrhosis in kazakh population.
Massabayeva MR; Aukenov NE; Mussazhanova ZB; Saenko VA; Rogounovitch TI; Shaimardanov NK; Kurmanova BR; Barkibaeva NR; Rakhypbekov TK
Vopr Virusol; 2016; 61(5):212-9. PubMed ID: 29323853
[TBL] [Abstract][Full Text] [Related]
39. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
40. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.
Neamatallah M; El-Bendary M; Elalfy H; Besheer T; El-Maksoud MA; Elhammady D; Abed S; Elegezy M; Kandeel L; Eldeib D; Mousa N; Abd El-Hafeez M; El-Gilany AH; Esmat G
Immunol Invest; 2020 May; 49(4):462-476. PubMed ID: 31615295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
